Click for best price
Nonalcoholic Steatohepatitis Market Size, Share 2023
| Market size in 2022 |
US$ 3277.4 million
|
Forecast Market size by 2029 |
US$ 11540 million
|
| Growth Rate |
CAGR of 19.7% |
Number of Pages |
112 Pages |
The global Non-alcoholic Steatohepatitis market was valued at US$ 3277.4 million in 2022 and is projected to reach US$ 11540 million by 2029, at a CAGR of 19.7% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Non-alcoholic steatohepatitis?(NASH) is an advanced form of?non-alcoholic fatty liver disease?(NAFLD). NAFLD is caused by buildup of fat in the liver. When this buildup causes inflammation and damage, it is known as NASH, which can lead to scarring of the liver.
This report aims to provide a comprehensive presentation of the global market for Non-alcoholic Steatohepatitis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-alcoholic Steatohepatitis. This report contains market size and forecasts of Non-alcoholic Steatohepatitis in global, including the following market information:
- Global Non-alcoholic Steatohepatitis Market Revenue, 2018-2023, 2024-2029, ($ millions)
- Global Non-alcoholic Steatohepatitis Market Sales, 2018-2023, 2024-2029, (MT)
- Global top five Non-alcoholic Steatohepatitis companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Solid Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Non-alcoholic Steatohepatitis include AstraZeneca, Arena Pharmaceuticals, GSK, Novo Nordisk, Roche, Vivus, Arisaph Pharmaceuticals, Cempra Pharmaceuticals and Galectin Therapeutics, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Non-alcoholic Steatohepatitis manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Non-alcoholic Steatohepatitis Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (MT)
Global Non-alcoholic Steatohepatitis Market Segment Percentages, by Type, 2022 (%)
Solid
Liquid
Global Non-alcoholic Steatohepatitis Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (MT)
Global Non-alcoholic Steatohepatitis Market Segment Percentages, by Application, 2022 (%)
Oral
Parenteral
Global Non-alcoholic Steatohepatitis Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (MT)
Global Non-alcoholic Steatohepatitis Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Non-alcoholic Steatohepatitis revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Non-alcoholic Steatohepatitis revenues share in global market, 2022 (%)
Key companies Non-alcoholic Steatohepatitis sales in global market, 2018-2023 (Estimated), (MT)
Key companies Non-alcoholic Steatohepatitis sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca
Arena Pharmaceuticals
GSK
Novo Nordisk
Roche
Vivus
Arisaph Pharmaceuticals
Cempra Pharmaceuticals
Galectin Therapeutics
Galmed Pharmaceuticals
Genfit
Gilead
Immuron
Interceptpharma
Raptor Pharmaceutical
Takeda
Tobira Therapeutics
Verva
Viking Therapeutics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Non-alcoholic Steatohepatitis, market overview.
Chapter 2: Global Non-alcoholic Steatohepatitis market size in revenue and volume.
Chapter 3: Detailed analysis of Non-alcoholic Steatohepatitis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Non-alcoholic Steatohepatitis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Non-alcoholic Steatohepatitis capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Non-alcoholic Steatohepatitis Market, Global Outlook and Forecast 2023-2029 |
| Market size in 2022 |
US$ 3277.4 million
|
| Forecast Market size by 2029 |
US$ 11540 million
|
| Growth Rate |
CAGR of 19.7% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
112 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Non-alcoholic Steatohepatitis Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Non-alcoholic Steatohepatitis Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Non-alcoholic Steatohepatitis Overall Market Size
2.1 Global Non-alcoholic Steatohepatitis Market Size: 2022 VS 2029
2.2 Global Non-alcoholic Steatohepatitis Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Non-alcoholic Steatohepatitis Sales: 2018-2029
3 Company Landscape
3.1 Top Non-alcoholic Steatohepatitis Players in Global Market
3.2 Top Global Non-alcoholic Steatohepatitis Companies Ranked by Revenue
3.3 Global Non-alcoholic Steatohepatitis Revenue by Companies
3.4 Global Non-alcoholic Steatohepatitis Sales by Companies
3.5 Global Non-alcoholic Steatohepatitis Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Non-alcoholic Steatohepatitis Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Non-alcoholic Steatohepatitis Product Type
3.8 Tier 1, Tier 2 and Tier 3 Non-alcoholic Steatohepatitis Players in Global Market
3.8.1 List of Global Tier 1 Non-alcoholic Steatohepatitis Companies
3.8.2 List of Global Tier 2 and Tier 3 Non-alcoholic Steatohepatitis Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Non-alcoholic Steatohepatitis Market Size Markets, 2022 & 2029
4.1.2 Solid
4.1.3 Liquid
4.2 By Type - Global Non-alcoholic Steatohepatitis Revenue & Forecasts
4.2.1 By Type - Global Non-alcoholic Steatohepatitis Revenue, 2018-2023
4.2.2 By Type - Global Non-alcoholic Steatohepatitis Revenue, 2024-2029
4.2.3 By Type - Global Non-alcoholic Steatohepatitis Revenue Market Share, 2018-2029
4.3 By Type - Global Non-alcoholic Steatohepatitis Sales & Forecasts
4.3.1 By Type - Global Non-alcoholic Steatohepatitis Sales, 2018-2023
4.3.2 By Type - Global Non-alcoholic Steatohepatitis Sales, 2024-2029
4.3.3 By Type - Global Non-alcoholic Steatohepatitis Sales Market Share, 2018-2029
4.4 By Type - Global Non-alcoholic Steatohepatitis Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Non-alcoholic Steatohepatitis Market Size, 2022 & 2029
5.1.2 Oral
5.1.3 Parenteral
5.2 By Application - Global Non-alcoholic Steatohepatitis Revenue & Forecasts
5.2.1 By Application - Global Non-alcoholic Steatohepatitis Revenue, 2018-2023
5.2.2 By Application - Global Non-alcoholic Steatohepatitis Revenue, 2024-2029
5.2.3 By Application - Global Non-alcoholic Steatohepatitis Revenue Market Share, 2018-2029
5.3 By Application - Global Non-alcoholic Steatohepatitis Sales & Forecasts
5.3.1 By Application - Global Non-alcoholic Steatohepatitis Sales, 2018-2023
5.3.2 By Application - Global Non-alcoholic Steatohepatitis Sales, 2024-2029
5.3.3 By Application - Global Non-alcoholic Steatohepatitis Sales Market Share, 2018-2029
5.4 By Application - Global Non-alcoholic Steatohepatitis Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Non-alcoholic Steatohepatitis Market Size, 2022 & 2029
6.2 By Region - Global Non-alcoholic Steatohepatitis Revenue & Forecasts
6.2.1 By Region - Global Non-alcoholic Steatohepatitis Revenue, 2018-2023
6.2.2 By Region - Global Non-alcoholic Steatohepatitis Revenue, 2024-2029
6.2.3 By Region - Global Non-alcoholic Steatohepatitis Revenue Market Share, 2018-2029
6.3 By Region - Global Non-alcoholic Steatohepatitis Sales & Forecasts
6.3.1 By Region - Global Non-alcoholic Steatohepatitis Sales, 2018-2023
6.3.2 By Region - Global Non-alcoholic Steatohepatitis Sales, 2024-2029
6.3.3 By Region - Global Non-alcoholic Steatohepatitis Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Non-alcoholic Steatohepatitis Revenue, 2018-2029
6.4.2 By Country - North America Non-alcoholic Steatohepatitis Sales, 2018-2029
6.4.3 US Non-alcoholic Steatohepatitis Market Size, 2018-2029
6.4.4 Canada Non-alcoholic Steatohepatitis Market Size, 2018-2029
6.4.5 Mexico Non-alcoholic Steatohepatitis Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Non-alcoholic Steatohepatitis Revenue, 2018-2029
6.5.2 By Country - Europe Non-alcoholic Steatohepatitis Sales, 2018-2029
6.5.3 Germany Non-alcoholic Steatohepatitis Market Size, 2018-2029
6.5.4 France Non-alcoholic Steatohepatitis Market Size, 2018-2029
6.5.5 U.K. Non-alcoholic Steatohepatitis Market Size, 2018-2029
6.5.6 Italy Non-alcoholic Steatohepatitis Market Size, 2018-2029
6.5.7 Russia Non-alcoholic Steatohepatitis Market Size, 2018-2029
6.5.8 Nordic Countries Non-alcoholic Steatohepatitis Market Size, 2018-2029
6.5.9 Benelux Non-alcoholic Steatohepatitis Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Non-alcoholic Steatohepatitis Revenue, 2018-2029
6.6.2 By Region - Asia Non-alcoholic Steatohepatitis Sales, 2018-2029
6.6.3 China Non-alcoholic Steatohepatitis Market Size, 2018-2029
6.6.4 Japan Non-alcoholic Steatohepatitis Market Size, 2018-2029
6.6.5 South Korea Non-alcoholic Steatohepatitis Market Size, 2018-2029
6.6.6 Southeast Asia Non-alcoholic Steatohepatitis Market Size, 2018-2029
6.6.7 India Non-alcoholic Steatohepatitis Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Non-alcoholic Steatohepatitis Revenue, 2018-2029
6.7.2 By Country - South America Non-alcoholic Steatohepatitis Sales, 2018-2029
6.7.3 Brazil Non-alcoholic Steatohepatitis Market Size, 2018-2029
6.7.4 Argentina Non-alcoholic Steatohepatitis Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Non-alcoholic Steatohepatitis Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Non-alcoholic Steatohepatitis Sales, 2018-2029
6.8.3 Turkey Non-alcoholic Steatohepatitis Market Size, 2018-2029
6.8.4 Israel Non-alcoholic Steatohepatitis Market Size, 2018-2029
6.8.5 Saudi Arabia Non-alcoholic Steatohepatitis Market Size, 2018-2029
6.8.6 UAE Non-alcoholic Steatohepatitis Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 AstraZeneca
7.1.1 AstraZeneca Company Summary
7.1.2 AstraZeneca Business Overview
7.1.3 AstraZeneca Non-alcoholic Steatohepatitis Major Product Offerings
7.1.4 AstraZeneca Non-alcoholic Steatohepatitis Sales and Revenue in Global (2018-2023)
7.1.5 AstraZeneca Key News & Latest Developments
7.2 Arena Pharmaceuticals
7.2.1 Arena Pharmaceuticals Company Summary
7.2.2 Arena Pharmaceuticals Business Overview
7.2.3 Arena Pharmaceuticals Non-alcoholic Steatohepatitis Major Product Offerings
7.2.4 Arena Pharmaceuticals Non-alcoholic Steatohepatitis Sales and Revenue in Global (2018-2023)
7.2.5 Arena Pharmaceuticals Key News & Latest Developments
7.3 GSK
7.3.1 GSK Company Summary
7.3.2 GSK Business Overview
7.3.3 GSK Non-alcoholic Steatohepatitis Major Product Offerings
7.3.4 GSK Non-alcoholic Steatohepatitis Sales and Revenue in Global (2018-2023)
7.3.5 GSK Key News & Latest Developments
7.4 Novo Nordisk
7.4.1 Novo Nordisk Company Summary
7.4.2 Novo Nordisk Business Overview
7.4.3 Novo Nordisk Non-alcoholic Steatohepatitis Major Product Offerings
7.4.4 Novo Nordisk Non-alcoholic Steatohepatitis Sales and Revenue in Global (2018-2023)
7.4.5 Novo Nordisk Key News & Latest Developments
7.5 Roche
7.5.1 Roche Company Summary
7.5.2 Roche Business Overview
7.5.3 Roche Non-alcoholic Steatohepatitis Major Product Offerings
7.5.4 Roche Non-alcoholic Steatohepatitis Sales and Revenue in Global (2018-2023)
7.5.5 Roche Key News & Latest Developments
7.6 Vivus
7.6.1 Vivus Company Summary
7.6.2 Vivus Business Overview
7.6.3 Vivus Non-alcoholic Steatohepatitis Major Product Offerings
7.6.4 Vivus Non-alcoholic Steatohepatitis Sales and Revenue in Global (2018-2023)
7.6.5 Vivus Key News & Latest Developments
7.7 Arisaph Pharmaceuticals
7.7.1 Arisaph Pharmaceuticals Company Summary
7.7.2 Arisaph Pharmaceuticals Business Overview
7.7.3 Arisaph Pharmaceuticals Non-alcoholic Steatohepatitis Major Product Offerings
7.7.4 Arisaph Pharmaceuticals Non-alcoholic Steatohepatitis Sales and Revenue in Global (2018-2023)
7.7.5 Arisaph Pharmaceuticals Key News & Latest Developments
7.8 Cempra Pharmaceuticals
7.8.1 Cempra Pharmaceuticals Company Summary
7.8.2 Cempra Pharmaceuticals Business Overview
7.8.3 Cempra Pharmaceuticals Non-alcoholic Steatohepatitis Major Product Offerings
7.8.4 Cempra Pharmaceuticals Non-alcoholic Steatohepatitis Sales and Revenue in Global (2018-2023)
7.8.5 Cempra Pharmaceuticals Key News & Latest Developments
7.9 Galectin Therapeutics
7.9.1 Galectin Therapeutics Company Summary
7.9.2 Galectin Therapeutics Business Overview
7.9.3 Galectin Therapeutics Non-alcoholic Steatohepatitis Major Product Offerings
7.9.4 Galectin Therapeutics Non-alcoholic Steatohepatitis Sales and Revenue in Global (2018-2023)
7.9.5 Galectin Therapeutics Key News & Latest Developments
7.10 Galmed Pharmaceuticals
7.10.1 Galmed Pharmaceuticals Company Summary
7.10.2 Galmed Pharmaceuticals Business Overview
7.10.3 Galmed Pharmaceuticals Non-alcoholic Steatohepatitis Major Product Offerings
7.10.4 Galmed Pharmaceuticals Non-alcoholic Steatohepatitis Sales and Revenue in Global (2018-2023)
7.10.5 Galmed Pharmaceuticals Key News & Latest Developments
7.11 Genfit
7.11.1 Genfit Company Summary
7.11.2 Genfit Non-alcoholic Steatohepatitis Business Overview
7.11.3 Genfit Non-alcoholic Steatohepatitis Major Product Offerings
7.11.4 Genfit Non-alcoholic Steatohepatitis Sales and Revenue in Global (2018-2023)
7.11.5 Genfit Key News & Latest Developments
7.12 Gilead
7.12.1 Gilead Company Summary
7.12.2 Gilead Non-alcoholic Steatohepatitis Business Overview
7.12.3 Gilead Non-alcoholic Steatohepatitis Major Product Offerings
7.12.4 Gilead Non-alcoholic Steatohepatitis Sales and Revenue in Global (2018-2023)
7.12.5 Gilead Key News & Latest Developments
7.13 Immuron
7.13.1 Immuron Company Summary
7.13.2 Immuron Non-alcoholic Steatohepatitis Business Overview
7.13.3 Immuron Non-alcoholic Steatohepatitis Major Product Offerings
7.13.4 Immuron Non-alcoholic Steatohepatitis Sales and Revenue in Global (2018-2023)
7.13.5 Immuron Key News & Latest Developments
7.14 Interceptpharma
7.14.1 Interceptpharma Company Summary
7.14.2 Interceptpharma Business Overview
7.14.3 Interceptpharma Non-alcoholic Steatohepatitis Major Product Offerings
7.14.4 Interceptpharma Non-alcoholic Steatohepatitis Sales and Revenue in Global (2018-2023)
7.14.5 Interceptpharma Key News & Latest Developments
7.15 Raptor Pharmaceutical
7.15.1 Raptor Pharmaceutical Company Summary
7.15.2 Raptor Pharmaceutical Business Overview
7.15.3 Raptor Pharmaceutical Non-alcoholic Steatohepatitis Major Product Offerings
7.15.4 Raptor Pharmaceutical Non-alcoholic Steatohepatitis Sales and Revenue in Global (2018-2023)
7.15.5 Raptor Pharmaceutical Key News & Latest Developments
7.16 Takeda
7.16.1 Takeda Company Summary
7.16.2 Takeda Business Overview
7.16.3 Takeda Non-alcoholic Steatohepatitis Major Product Offerings
7.16.4 Takeda Non-alcoholic Steatohepatitis Sales and Revenue in Global (2018-2023)
7.16.5 Takeda Key News & Latest Developments
7.17 Tobira Therapeutics
7.17.1 Tobira Therapeutics Company Summary
7.17.2 Tobira Therapeutics Business Overview
7.17.3 Tobira Therapeutics Non-alcoholic Steatohepatitis Major Product Offerings
7.17.4 Tobira Therapeutics Non-alcoholic Steatohepatitis Sales and Revenue in Global (2018-2023)
7.17.5 Tobira Therapeutics Key News & Latest Developments
7.18 Verva
7.18.1 Verva Company Summary
7.18.2 Verva Business Overview
7.18.3 Verva Non-alcoholic Steatohepatitis Major Product Offerings
7.18.4 Verva Non-alcoholic Steatohepatitis Sales and Revenue in Global (2018-2023)
7.18.5 Verva Key News & Latest Developments
7.19 Viking Therapeutics
7.19.1 Viking Therapeutics Company Summary
7.19.2 Viking Therapeutics Business Overview
7.19.3 Viking Therapeutics Non-alcoholic Steatohepatitis Major Product Offerings
7.19.4 Viking Therapeutics Non-alcoholic Steatohepatitis Sales and Revenue in Global (2018-2023)
7.19.5 Viking Therapeutics Key News & Latest Developments
8 Global Non-alcoholic Steatohepatitis Production Capacity, Analysis
8.1 Global Non-alcoholic Steatohepatitis Production Capacity, 2018-2029
8.2 Non-alcoholic Steatohepatitis Production Capacity of Key Manufacturers in Global Market
8.3 Global Non-alcoholic Steatohepatitis Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Non-alcoholic Steatohepatitis Supply Chain Analysis
10.1 Non-alcoholic Steatohepatitis Industry Value Chain
10.2 Non-alcoholic Steatohepatitis Upstream Market
10.3 Non-alcoholic Steatohepatitis Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Non-alcoholic Steatohepatitis Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Non-alcoholic Steatohepatitis in Global Market
Table 2. Top Non-alcoholic Steatohepatitis Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Non-alcoholic Steatohepatitis Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Non-alcoholic Steatohepatitis Revenue Share by Companies, 2018-2023
Table 5. Global Non-alcoholic Steatohepatitis Sales by Companies, (MT), 2018-2023
Table 6. Global Non-alcoholic Steatohepatitis Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Non-alcoholic Steatohepatitis Price (2018-2023) & (USD/Kg)
Table 8. Global Manufacturers Non-alcoholic Steatohepatitis Product Type
Table 9. List of Global Tier 1 Non-alcoholic Steatohepatitis Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Non-alcoholic Steatohepatitis Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Non-alcoholic Steatohepatitis Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Non-alcoholic Steatohepatitis Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Non-alcoholic Steatohepatitis Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Non-alcoholic Steatohepatitis Sales (MT), 2018-2023
Table 15. By Type - Global Non-alcoholic Steatohepatitis Sales (MT), 2024-2029
Table 16. By Application ? Global Non-alcoholic Steatohepatitis Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Non-alcoholic Steatohepatitis Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Non-alcoholic Steatohepatitis Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Non-alcoholic Steatohepatitis Sales (MT), 2018-2023
Table 20. By Application - Global Non-alcoholic Steatohepatitis Sales (MT), 2024-2029
Table 21. By Region ? Global Non-alcoholic Steatohepatitis Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Non-alcoholic Steatohepatitis Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Non-alcoholic Steatohepatitis Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Non-alcoholic Steatohepatitis Sales (MT), 2018-2023
Table 25. By Region - Global Non-alcoholic Steatohepatitis Sales (MT), 2024-2029
Table 26. By Country - North America Non-alcoholic Steatohepatitis Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Non-alcoholic Steatohepatitis Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Non-alcoholic Steatohepatitis Sales, (MT), 2018-2023
Table 29. By Country - North America Non-alcoholic Steatohepatitis Sales, (MT), 2024-2029
Table 30. By Country - Europe Non-alcoholic Steatohepatitis Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Non-alcoholic Steatohepatitis Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Non-alcoholic Steatohepatitis Sales, (MT), 2018-2023
Table 33. By Country - Europe Non-alcoholic Steatohepatitis Sales, (MT), 2024-2029
Table 34. By Region - Asia Non-alcoholic Steatohepatitis Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Non-alcoholic Steatohepatitis Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Non-alcoholic Steatohepatitis Sales, (MT), 2018-2023
Table 37. By Region - Asia Non-alcoholic Steatohepatitis Sales, (MT), 2024-2029
Table 38. By Country - South America Non-alcoholic Steatohepatitis Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Non-alcoholic Steatohepatitis Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Non-alcoholic Steatohepatitis Sales, (MT), 2018-2023
Table 41. By Country - South America Non-alcoholic Steatohepatitis Sales, (MT), 2024-2029
Table 42. By Country - Middle East & Africa Non-alcoholic Steatohepatitis Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Non-alcoholic Steatohepatitis Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Non-alcoholic Steatohepatitis Sales, (MT), 2018-2023
Table 45. By Country - Middle East & Africa Non-alcoholic Steatohepatitis Sales, (MT), 2024-2029
Table 46. AstraZeneca Company Summary
Table 47. AstraZeneca Non-alcoholic Steatohepatitis Product Offerings
Table 48. AstraZeneca Non-alcoholic Steatohepatitis Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2018-2023)
Table 49. AstraZeneca Key News & Latest Developments
Table 50. Arena Pharmaceuticals Company Summary
Table 51. Arena Pharmaceuticals Non-alcoholic Steatohepatitis Product Offerings
Table 52. Arena Pharmaceuticals Non-alcoholic Steatohepatitis Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2018-2023)
Table 53. Arena Pharmaceuticals Key News & Latest Developments
Table 54. GSK Company Summary
Table 55. GSK Non-alcoholic Steatohepatitis Product Offerings
Table 56. GSK Non-alcoholic Steatohepatitis Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2018-2023)
Table 57. GSK Key News & Latest Developments
Table 58. Novo Nordisk Company Summary
Table 59. Novo Nordisk Non-alcoholic Steatohepatitis Product Offerings
Table 60. Novo Nordisk Non-alcoholic Steatohepatitis Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2018-2023)
Table 61. Novo Nordisk Key News & Latest Developments
Table 62. Roche Company Summary
Table 63. Roche Non-alcoholic Steatohepatitis Product Offerings
Table 64. Roche Non-alcoholic Steatohepatitis Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2018-2023)
Table 65. Roche Key News & Latest Developments
Table 66. Vivus Company Summary
Table 67. Vivus Non-alcoholic Steatohepatitis Product Offerings
Table 68. Vivus Non-alcoholic Steatohepatitis Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2018-2023)
Table 69. Vivus Key News & Latest Developments
Table 70. Arisaph Pharmaceuticals Company Summary
Table 71. Arisaph Pharmaceuticals Non-alcoholic Steatohepatitis Product Offerings
Table 72. Arisaph Pharmaceuticals Non-alcoholic Steatohepatitis Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2018-2023)
Table 73. Arisaph Pharmaceuticals Key News & Latest Developments
Table 74. Cempra Pharmaceuticals Company Summary
Table 75. Cempra Pharmaceuticals Non-alcoholic Steatohepatitis Product Offerings
Table 76. Cempra Pharmaceuticals Non-alcoholic Steatohepatitis Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2018-2023)
Table 77. Cempra Pharmaceuticals Key News & Latest Developments
Table 78. Galectin Therapeutics Company Summary
Table 79. Galectin Therapeutics Non-alcoholic Steatohepatitis Product Offerings
Table 80. Galectin Therapeutics Non-alcoholic Steatohepatitis Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2018-2023)
Table 81. Galectin Therapeutics Key News & Latest Developments
Table 82. Galmed Pharmaceuticals Company Summary
Table 83. Galmed Pharmaceuticals Non-alcoholic Steatohepatitis Product Offerings
Table 84. Galmed Pharmaceuticals Non-alcoholic Steatohepatitis Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2018-2023)
Table 85. Galmed Pharmaceuticals Key News & Latest Developments
Table 86. Genfit Company Summary
Table 87. Genfit Non-alcoholic Steatohepatitis Product Offerings
Table 88. Genfit Non-alcoholic Steatohepatitis Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2018-2023)
Table 89. Genfit Key News & Latest Developments
Table 90. Gilead Company Summary
Table 91. Gilead Non-alcoholic Steatohepatitis Product Offerings
Table 92. Gilead Non-alcoholic Steatohepatitis Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2018-2023)
Table 93. Gilead Key News & Latest Developments
Table 94. Immuron Company Summary
Table 95. Immuron Non-alcoholic Steatohepatitis Product Offerings
Table 96. Immuron Non-alcoholic Steatohepatitis Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2018-2023)
Table 97. Immuron Key News & Latest Developments
Table 98. Interceptpharma Company Summary
Table 99. Interceptpharma Non-alcoholic Steatohepatitis Product Offerings
Table 100. Interceptpharma Non-alcoholic Steatohepatitis Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2018-2023)
Table 101. Interceptpharma Key News & Latest Developments
Table 102. Raptor Pharmaceutical Company Summary
Table 103. Raptor Pharmaceutical Non-alcoholic Steatohepatitis Product Offerings
Table 104. Raptor Pharmaceutical Non-alcoholic Steatohepatitis Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2018-2023)
Table 105. Raptor Pharmaceutical Key News & Latest Developments
Table 106. Takeda Company Summary
Table 107. Takeda Non-alcoholic Steatohepatitis Product Offerings
Table 108. Takeda Non-alcoholic Steatohepatitis Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2018-2023)
Table 109. Takeda Key News & Latest Developments
Table 110. Tobira Therapeutics Company Summary
Table 111. Tobira Therapeutics Non-alcoholic Steatohepatitis Product Offerings
Table 112. Tobira Therapeutics Non-alcoholic Steatohepatitis Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2018-2023)
Table 113. Tobira Therapeutics Key News & Latest Developments
Table 114. Verva Company Summary
Table 115. Verva Non-alcoholic Steatohepatitis Product Offerings
Table 116. Verva Non-alcoholic Steatohepatitis Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2018-2023)
Table 117. Verva Key News & Latest Developments
Table 118. Viking Therapeutics Company Summary
Table 119. Viking Therapeutics Non-alcoholic Steatohepatitis Product Offerings
Table 120. Viking Therapeutics Non-alcoholic Steatohepatitis Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2018-2023)
Table 121. Viking Therapeutics Key News & Latest Developments
Table 122. Non-alcoholic Steatohepatitis Production Capacity (MT) of Key Manufacturers in Global Market, 2021-2023 (MT)
Table 123. Global Non-alcoholic Steatohepatitis Capacity Market Share of Key Manufacturers, 2021-2023
Table 124. Global Non-alcoholic Steatohepatitis Production by Region, 2018-2023 (MT)
Table 125. Global Non-alcoholic Steatohepatitis Production by Region, 2024-2029 (MT)
Table 126. Non-alcoholic Steatohepatitis Market Opportunities & Trends in Global Market
Table 127. Non-alcoholic Steatohepatitis Market Drivers in Global Market
Table 128. Non-alcoholic Steatohepatitis Market Restraints in Global Market
Table 129. Non-alcoholic Steatohepatitis Raw Materials
Table 130. Non-alcoholic Steatohepatitis Raw Materials Suppliers in Global Market
Table 131. Typical Non-alcoholic Steatohepatitis Downstream
Table 132. Non-alcoholic Steatohepatitis Downstream Clients in Global Market
Table 133. Non-alcoholic Steatohepatitis Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Non-alcoholic Steatohepatitis Segment by Type in 2022
Figure 2. Non-alcoholic Steatohepatitis Segment by Application in 2022
Figure 3. Global Non-alcoholic Steatohepatitis Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Non-alcoholic Steatohepatitis Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Non-alcoholic Steatohepatitis Revenue, 2018-2029 (US$, Mn)
Figure 7. Non-alcoholic Steatohepatitis Sales in Global Market: 2018-2029 (MT)
Figure 8. The Top 3 and 5 Players Market Share by Non-alcoholic Steatohepatitis Revenue in 2022
Figure 9. By Type - Global Non-alcoholic Steatohepatitis Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Non-alcoholic Steatohepatitis Revenue Market Share, 2018-2029
Figure 11. By Type - Global Non-alcoholic Steatohepatitis Sales Market Share, 2018-2029
Figure 12. By Type - Global Non-alcoholic Steatohepatitis Price (USD/Kg), 2018-2029
Figure 13. By Application - Global Non-alcoholic Steatohepatitis Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Non-alcoholic Steatohepatitis Revenue Market Share, 2018-2029
Figure 15. By Application - Global Non-alcoholic Steatohepatitis Sales Market Share, 2018-2029
Figure 16. By Application - Global Non-alcoholic Steatohepatitis Price (USD/Kg), 2018-2029
Figure 17. By Region - Global Non-alcoholic Steatohepatitis Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Non-alcoholic Steatohepatitis Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Non-alcoholic Steatohepatitis Revenue Market Share, 2018-2029
Figure 20. By Region - Global Non-alcoholic Steatohepatitis Sales Market Share, 2018-2029
Figure 21. By Country - North America Non-alcoholic Steatohepatitis Revenue Market Share, 2018-2029
Figure 22. By Country - North America Non-alcoholic Steatohepatitis Sales Market Share, 2018-2029
Figure 23. US Non-alcoholic Steatohepatitis Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Non-alcoholic Steatohepatitis Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Non-alcoholic Steatohepatitis Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Non-alcoholic Steatohepatitis Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Non-alcoholic Steatohepatitis Sales Market Share, 2018-2029
Figure 28. Germany Non-alcoholic Steatohepatitis Revenue, (US$, Mn), 2018-2029
Figure 29. France Non-alcoholic Steatohepatitis Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Non-alcoholic Steatohepatitis Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Non-alcoholic Steatohepatitis Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Non-alcoholic Steatohepatitis Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Non-alcoholic Steatohepatitis Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Non-alcoholic Steatohepatitis Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Non-alcoholic Steatohepatitis Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Non-alcoholic Steatohepatitis Sales Market Share, 2018-2029
Figure 37. China Non-alcoholic Steatohepatitis Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Non-alcoholic Steatohepatitis Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Non-alcoholic Steatohepatitis Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Non-alcoholic Steatohepatitis Revenue, (US$, Mn), 2018-2029
Figure 41. India Non-alcoholic Steatohepatitis Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Non-alcoholic Steatohepatitis Revenue Market Share, 2018-2029
Figure 43. By Country - South America Non-alcoholic Steatohepatitis Sales Market Share, 2018-2029
Figure 44. Brazil Non-alcoholic Steatohepatitis Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Non-alcoholic Steatohepatitis Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Non-alcoholic Steatohepatitis Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Non-alcoholic Steatohepatitis Sales Market Share, 2018-2029
Figure 48. Turkey Non-alcoholic Steatohepatitis Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Non-alcoholic Steatohepatitis Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Non-alcoholic Steatohepatitis Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Non-alcoholic Steatohepatitis Revenue, (US$, Mn), 2018-2029
Figure 52. Global Non-alcoholic Steatohepatitis Production Capacity (MT), 2018-2029
Figure 53. The Percentage of Production Non-alcoholic Steatohepatitis by Region, 2022 VS 2029
Figure 54. Non-alcoholic Steatohepatitis Industry Value Chain
Figure 55. Marketing Channels
